Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1604

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 7
Chunk 1604
---
,038) 
    $4,798,096 

(1)Periods presented have been adjusted to reflect the 1:12 reverse stock split on August 12, 2024 and the 1:5 reverse stock split on February 24, 2025.

See accompanying notes to these consolidated
financial statements which are an integral part of these consolidated financial statements.

F-6

 60 DEGREES
PHARMACEUTICALS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

    For the Years Ended December 31, 
    2024  
    2023 
  
    CASH FLOWS FROM OPERATING ACTIVITIES 

    Net Loss 
    $(7,955,663) 
    $(3,813,800)
  
    Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities: 

    Depreciation 
     11,726  
     21,162 
  
    Amortization 
     38,502  
     29,157 
  
    Amortization of Debt Discount 
     -  
     669,148 
  
    Amortization of ROU Asset 
     13,517  
     50,053 
  
    Amortization of Note Issuance Costs 
     -  
     67,728 
  
    Amortization of Capitalized Share-Based Payments 
     3,575,881  
     994,643 
  
    Share-Based Compensation to Vendors for Services 
     -  
     212,605 
  
    Share-Based Compensation under Equity Incentive Plan 
     32,767  
     528,926 
  
    Deemed Capital Contribution for Related Party Compensation Expense (Note 10) 
        
     163,228 
  
    Loss on Debt Extinguishment 
     -  
     1,231,480 
  
    Change in Fair Value of Derivative Liabilities 
     (1,665,966) 
     37,278 
  
    Derivative Expense 
     -  
     399,725 
  
    Change in Fair Value of Promissory Note 
     -  
     (5,379,269)
  
    Write-offs of Capitalized Patents 
     108,424  
     - 
  
    Inventory Reserve 
     -